New Once-a-Day transplant pill tested for better heart health
NCT ID NCT03841097
Summary
This study compares two versions of the same anti-rejection medication for kidney transplant patients. Researchers want to see if a new once-daily pill is better for blood vessel health and provides more consistent drug levels than the standard twice-daily version. The study involves 60 African American kidney transplant recipients who will be followed for up to a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT; COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.